Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
00:24:48 EDT Thu 03 Jul 2025
Enter Symbol
or Name
USA
CA



Z:DHR - DANAHER CORP - https://www.danaher.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
DHR - Z0.1182.33·205.001.0202.50+1.360.73,503.7703,45233,997202.18  203.3953  199.30281.70  171.0019:14:37Jun 2715 min RT 2¢

Recent Trades - Last 10 of 33997
Time ETExPriceChangeVolume
19:14:37Z203.001.9050
19:04:44Z203.001.9020
18:59:58Z203.852.752
18:55:03Z203.752.652
18:37:33Z203.852.756
18:36:59Z203.852.754
18:36:27Z203.852.752
18:35:02Z203.852.753
18:33:57Z203.67882.57881
18:33:30Z203.852.751

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2025-06-27 07:35U:DHRNews ReleaseDanaher Appoints Martin Stumpe as Chief Technology and AI Officer
2025-06-27 07:30U:DHRNews ReleaseDanaher appoints Greg Milosevich to Executive Vice President, Life Sciences
2025-06-17 16:30U:DHRNews ReleaseDanaher Schedules Second Quarter 2025 Earnings Conference Call
2025-06-02 07:00U:DHRNews ReleaseSCIEX Sets a New Standard in Accurate Mass Quantitation With the ZenoTOF 8600 System and New Software Collaborations
2025-06-02 07:00U:DHRNews ReleaseSoftware Launches for SCIEX OS Ecosystem to Help Scientists Accelerate Discoveries and Streamline Lab Operations
2025-06-02 07:00U:DHRNews ReleaseSCIEX and Evosep expand access to standardized proteomics for Pharma and Biotech with new reseller agreement
2025-05-29 16:30U:DHRNews ReleaseDanaher Announces Diagnostic Development and Commercialization Partnership to Scale Precision Medicine
2025-05-15 13:00U:DHRNews ReleaseAldevron and Integrated DNA Technologies Manufacture World's First mRNA-based Personalized CRISPR Therapy
2025-05-07 16:15U:DHRNews ReleaseDanaher to Present at Bank of America Securities Healthcare Conference
2025-05-06 16:15U:DHRNews ReleaseDanaher Announces Quarterly Dividend
2025-04-29 10:07U:DHRNews ReleaseKytopen and Aldevron Expedite Cell Therapy Manufacturing Through Their Collaborative CRISPR-mediated Cellular Engineering Workflow
2025-04-22 06:00U:DHRNews ReleaseDanaher Reports First Quarter 2025 Results
2025-03-20 16:15U:DHRNews ReleaseDanaher Schedules First Quarter 2025 Earnings Conference Call
2025-03-10 08:30U:DHRNews ReleaseBeckman Coulter Announces FDA clearance of DxC 500i Clinical Analyzer, an integrated Clinical Chemistry and Immunoassay System
2025-02-25 16:15U:DHRNews ReleaseDanaher to Present at TD Cowen Health Care Conference
2025-02-20 16:45U:DHRNews ReleaseDanaher Announces Appointment of Charles Lamanna to Danaher Board
2025-02-20 16:15U:DHRNews ReleaseDanaher Increases Quarterly Dividend
2025-01-29 06:00U:DHRNews ReleaseDanaher Reports Fourth Quarter and Full Year 2024 Results
2025-01-15 08:30U:DHRNews ReleaseBeckman Coulter Introduces Cutting-Edge Research Use Only Assays for Neurodegenerative Disease Research
2025-01-13 16:15U:DHRNews ReleaseDanaher CEO to Comment on Financial Performance